Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 9002-18-0
2. (2r,3s,4s,5r)-2-(hydroxymethyl)-6-[[(4r,5s)-4-hydroxy-3-methyl-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-methoxyoxane-3,5-diol
3. Mfcd00081288
4. Agar (bacteriological)
5. Gum-agar
6. Agar, Plant Cell Culture Tested
7. Agar, Pure, Powder Bacteriology And Molecular Biology Grade
| Molecular Weight | 336.33 g/mol |
|---|---|
| Molecular Formula | C14H24O9 |
| XLogP3 | -2.2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | 336.14203234 g/mol |
| Monoisotopic Mass | 336.14203234 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 408 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 6 |
| Undefined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
IT MAY BE EATEN AS A CEREAL SUBSTITUTE OR ADDED TO OTHER FOODS, OR IT MAY BE DISSOLVED IN HOT WATER & ALLOWED TO GEL BEFORE BEING TAKEN. HOWEVER, AGAR IS A RELATIVELY INEFFECTIVE BULK-FORMING AGENT IN THE USUAL DOSE OF 4 TO 16 G.
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 979
...ALSO EMPLOYED AS AN EMULSIFYING AGENT IN A VARIETY OF PROPRIETARY NOSTRUMS COMBINED WITH MINERAL OIL & OTHER CATHARTICS, BUT THE DOSE OF AGAR IN THESE PREPARATIONS IS TOO SMALL TO CONTRIBUTE TO THEIR LAXATIVE EFFECT.
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 979
MEDICATION (VET): LAXATIVE...USED IN CONSTIPATION.
Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 6
MECHANISTIC STUDIES REVEALED ANTIPEPTIC EFFECT OF AGAR WAS DUE TO A SUBSTRATE-INHIBITOR INTERACTION WITH HEMOGLOBIN. POSSIBLE SIGNIFICANCE IN THE INHIBITORY EFFECT OF AGAR IN ULCER THERAPY.
GOUDA MW; JODHKA G; INHIBITORY EFFECT OF AGAR ON PEPSIN ACTIVITY; CAN J PHARM SCI 12 (1): 4 (1977)
For more Therapeutic Uses (Complete) data for AGAR-AGAR (6 total), please visit the HSDB record page.
1(?)= PRACTICALLY NON-TOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN) ABOVE 15 G/KG, MORE THAN 1 QUART FOR 70 KG PERSON (150 LB). /GUMS, VEGETABLE/
Gosselin, R.E., H.C. Hodge, R.P. Smith, and M.N. Gleason. Clinical Toxicology of Commercial Products. 4th ed. Baltimore: Williams and Wilkins, 1976., p. II-6
Culture Media
Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. (See all compounds classified as Culture Media.)
It passes through the intestinal tract mostly unabsorbed.
Leung, A.Y., Foster, S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics. New York, NY. John Wiley & Sons, Inc. 1996., p. 10
THESE SUBSTANCES DISSOLVE OR SWELL IN WATER TO FORM AN EMOLLIENT GEL OR VISCOUS SOLN THAT SERVES TO MAINTAIN THE FECES SOFT & HYDRATED. THE RESULTING BULK PROMOTES PERISTALSIS, & TRANSIT TIME IS REDUCED. /BULK-FORMING LAXATIVES/
Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 978
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
27
PharmaCompass offers a list of Agar API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Agar manufacturer or Agar supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Agar manufacturer or Agar supplier.
PharmaCompass also assists you with knowing the Agar API Price utilized in the formulation of products. Agar API Price is not always fixed or binding as the Agar Price is obtained through a variety of data sources. The Agar Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Agar manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Agar, including repackagers and relabelers. The FDA regulates Agar manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Agar API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Agar supplier is an individual or a company that provides Agar active pharmaceutical ingredient (API) or Agar finished formulations upon request. The Agar suppliers may include Agar API manufacturers, exporters, distributors and traders.
click here to find a list of Agar suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Agar CEP of the European Pharmacopoeia monograph is often referred to as a Agar Certificate of Suitability (COS). The purpose of a Agar CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Agar EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Agar to their clients by showing that a Agar CEP has been issued for it. The manufacturer submits a Agar CEP (COS) as part of the market authorization procedure, and it takes on the role of a Agar CEP holder for the record. Additionally, the data presented in the Agar CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Agar DMF.
A Agar CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Agar CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Agar suppliers with CEP (COS) on PharmaCompass.
Agar Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Agar GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Agar GMP manufacturer or Agar GMP API supplier for your needs.
A Agar CoA (Certificate of Analysis) is a formal document that attests to Agar's compliance with Agar specifications and serves as a tool for batch-level quality control.
Agar CoA mostly includes findings from lab analyses of a specific batch. For each Agar CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Agar may be tested according to a variety of international standards, such as European Pharmacopoeia (Agar EP), Agar JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Agar USP).
